Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

February 21, 2024 17:07 (London Time)

OKYO Pharma

Youtube Subscribe

...

Sector: Biotechnology
Ticker: OKYO
Sentiment: -0.6908
MarketCap: 48,524,633.0
High: 1.47 Low: 1.39

Open: 1.45 Close: 1.46 Change: 0.01

You're running out of time to find out about OKYO Pharma Company Inc using an AI.

This document will help you to evaluate OKYO Pharma without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about OKYO Pharma are: OKYO, Pharma, OK101, neuropathic, corneal, pain, low, …

Concept Map

...

Semantic Network

...

Stock Summary

OKYO Pharma Limited engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain. Its lead preclinical product candidate is OK-101 for the treatment of dry eye disease. OK-201 is a bov.

Today's Summary

OKYO Pharma has a 12-month low of $0.92 and a 12 month high of $7.00. OK-101 is a non-opioid analgesic designed to mitigate neuropathic corneal pain. OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Today's News

OKYO Pharma has a 12-month low of $0.92 and a 12 month high of $7.00. OK-101 is a non-opioid analgesic designed to mitigate neuropathic corneal pain. OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Stock Profile

"OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom."

Keywords

How much time have you spent trying to decide whether investing in OKYO Pharma? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about OKYO Pharma are: OKYO, Pharma, OK101, neuropathic, corneal, pain, low, and the most common words in the summary are: pharmaceutical, pharma, perform, inc, okyo, share, change, . One of the sentences in the summary was: OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharmaceutical #pharma #perform #inc #okyo #share #change.

Read more →

Related Results

...
February 21, 2024 17:07 (London Time)

OKYO Pharma

OKYO Pharma has a 12-month low of $0.92 and a 12 month high of $7.00. OK-101 is a non-opioid analgesic designed to mitigate neuropathic corneal pain…
Sector: Biotechnology
Ticker: OKYO
Sentiment: -0.6908
MarketCap: 48,524,633.0
High: 1.47 Low: 1.39

Open: 1.45 Close: 1.46 Change: 0.01

Read more →
...
August 19, 2023 3:53 (London Time)

OKYO Pharma

OKYO Pharma Limited is developing OK-101 to treat dry eye disease (“DED”) to address the significant unmet need in this multi-billion-dollar market.…
Sector: Biotechnology
Ticker: OKYO
Sentiment: 0.3818
MarketCap: 39,607,574.0
High: 1.7 Low: 1.38

Open: 1.5 Close: 1.63 Change: 0.13

Read more →
...
October 12, 2023 4:21 (London Time)

OKYO Pharma

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic…
Sector: Biotechnology
Ticker: OKYO
Sentiment: -0.5574
MarketCap: 52,206,896.0
High: 1.83 Low: 1.71

Open: 1.83 Close: 1.74 Change: -0.09

Read more →
...
July 09, 2023 21:32 (London Time)

OKYO Pharma

OKYO Pharma Ltd. has 8.41 million shares outstanding. The beta is -2.97, so the companys price volatility has been lower than the market average. Th…
Sector: Biotechnology
Ticker: OKYO
Sentiment: 0.6481
MarketCap: 27,563,907.0
High: 1.17 Low: 1.08

Open: 1.11 Close: 1.08 Change: -0.03

Read more →